CD8A and neoplasm: Wang et al found that IL-13 receptor α2-specific CD4+ CAR-T cells exhibited long-term cytotoxicity against primary glioblastoma cells, whereas CD8+ CAR-T cells exhibited short-term cytotoxicity but became exhausted, permitting tumor relapse [32].